Annual accounts receivable:
$609.10M-$162.40M(-21.05%)Summary
- As of today (June 22, 2025), EW annual accounts receivable is $609.10 million, with the most recent change of -$162.40 million (-21.05%) on December 31, 2024.
- During the last 3 years, EW annual accounts receivable has risen by +$26.90 million (+4.62%).
- EW annual accounts receivable is now -21.05% below its all-time high of $771.50 million, reached on December 31, 2023.
Performance
EW Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$669.20M+$60.10M(+9.87%)Summary
- As of today (June 22, 2025), EW quarterly accounts receivable is $669.20 million, with the most recent change of +$60.10 million (+9.87%) on March 1, 2025.
- Over the past year, EW quarterly accounts receivable has dropped by -$148.40 million (-18.15%).
- EW quarterly accounts receivable is now -18.15% below its all-time high of $817.60 million, reached on March 31, 2024.
Performance
EW Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
EW Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -21.1% | -18.1% |
| 3 y3 years | +4.6% | +5.2% |
| 5 y5 years | +12.1% | +14.4% |
EW Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -21.1% | +4.6% | -18.1% | +9.9% |
| 5 y | 5-year | -21.1% | +18.4% | -18.1% | +30.0% |
| alltime | all time | -21.1% | +614.1% | -18.1% | +684.5% |
EW Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $669.20M(+9.9%) |
| Dec 2024 | $609.10M(-21.0%) | $609.10M(-14.9%) |
| Sep 2024 | - | $716.00M(-8.0%) |
| Jun 2024 | - | $778.30M(-4.8%) |
| Mar 2024 | - | $817.60M(+6.0%) |
| Dec 2023 | $771.50M(+20.0%) | $771.50M(+4.3%) |
| Sep 2023 | - | $739.80M(-1.9%) |
| Jun 2023 | - | $754.40M(+5.1%) |
| Mar 2023 | - | $717.70M(+11.6%) |
| Dec 2022 | $643.00M(+10.4%) | $643.00M(+4.0%) |
| Sep 2022 | - | $618.10M(-2.9%) |
| Jun 2022 | - | $636.40M(+0.0%) |
| Mar 2022 | - | $636.30M(+9.3%) |
| Dec 2021 | $582.20M(+13.1%) | $582.20M(-3.1%) |
| Sep 2021 | - | $600.60M(-6.2%) |
| Jun 2021 | - | $640.50M(+9.2%) |
| Mar 2021 | - | $586.60M(+14.0%) |
| Dec 2020 | $514.60M(-5.3%) | $514.60M(-6.4%) |
| Sep 2020 | - | $549.70M(-3.2%) |
| Jun 2020 | - | $567.90M(-2.9%) |
| Mar 2020 | - | $585.10M(+7.6%) |
| Dec 2019 | $543.60M(+19.0%) | $543.60M(-4.6%) |
| Sep 2019 | - | $570.00M(-6.5%) |
| Jun 2019 | - | $609.60M(+5.5%) |
| Mar 2019 | - | $578.00M(+26.5%) |
| Dec 2018 | $456.90M(+4.1%) | $456.90M(+7.8%) |
| Sep 2018 | - | $423.80M(-1.8%) |
| Jun 2018 | - | $431.40M(+6.1%) |
| Mar 2018 | - | $406.60M(-7.3%) |
| Dec 2017 | $438.70M(+20.0%) | $438.70M(-7.6%) |
| Sep 2017 | - | $475.00M(-7.0%) |
| Jun 2017 | - | $510.70M(+0.1%) |
| Mar 2017 | - | $510.20M(+39.6%) |
| Dec 2016 | $365.50M(+15.9%) | $365.50M(-19.5%) |
| Sep 2016 | - | $454.20M(+6.7%) |
| Jun 2016 | - | $425.80M(+9.6%) |
| Mar 2016 | - | $388.50M(+23.2%) |
| Dec 2015 | $315.40M(+9.5%) | $315.40M(-6.8%) |
| Sep 2015 | - | $338.40M(-3.6%) |
| Jun 2015 | - | $351.00M(+1.7%) |
| Mar 2015 | - | $345.30M(+19.9%) |
| Dec 2014 | $288.00M(-4.8%) | $288.00M(-10.8%) |
| Sep 2014 | - | $322.90M(-1.4%) |
| Jun 2014 | - | $327.50M(+7.3%) |
| Mar 2014 | - | $305.10M(+0.9%) |
| Dec 2013 | $302.50M(-5.8%) | $302.50M(-7.7%) |
| Sep 2013 | - | $327.80M(-4.1%) |
| Jun 2013 | - | $341.80M(+3.7%) |
| Mar 2013 | - | $329.70M(+2.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $321.10M(+13.1%) | $321.10M(-1.3%) |
| Sep 2012 | - | $325.40M(-3.3%) |
| Jun 2012 | - | $336.40M(-3.0%) |
| Mar 2012 | - | $346.70M(+22.2%) |
| Dec 2011 | $283.80M(+2.3%) | $283.80M(-18.2%) |
| Sep 2011 | - | $346.80M(-4.8%) |
| Jun 2011 | - | $364.10M(+2.8%) |
| Mar 2011 | - | $354.20M(+27.7%) |
| Dec 2010 | $277.30M(+11.2%) | $277.30M(-8.6%) |
| Sep 2010 | - | $303.40M(+3.2%) |
| Jun 2010 | - | $294.00M(+5.5%) |
| Mar 2010 | - | $278.60M(+11.7%) |
| Dec 2009 | $249.40M(+33.9%) | $249.40M(-11.1%) |
| Sep 2009 | - | $280.50M(+2.2%) |
| Jun 2009 | - | $274.50M(+7.3%) |
| Mar 2009 | - | $255.80M(+37.3%) |
| Dec 2008 | $186.30M(+60.9%) | $186.30M(-12.8%) |
| Sep 2008 | - | $213.60M(+23.3%) |
| Jun 2008 | - | $173.30M(+11.6%) |
| Mar 2008 | - | $155.30M(+34.1%) |
| Dec 2007 | $115.80M(+3.9%) | $115.80M(-15.3%) |
| Sep 2007 | - | $136.70M(-0.5%) |
| Jun 2007 | - | $137.40M(+6.3%) |
| Mar 2007 | - | $129.30M(+16.0%) |
| Dec 2006 | $111.50M(-5.9%) | $111.50M(-14.4%) |
| Sep 2006 | - | $130.20M(-2.6%) |
| Jun 2006 | - | $133.70M(+8.7%) |
| Mar 2006 | - | $123.00M(+3.8%) |
| Dec 2005 | $118.50M(+13.8%) | $118.50M(-5.9%) |
| Sep 2005 | - | $125.90M(+0.8%) |
| Jun 2005 | - | $124.90M(-2.2%) |
| Mar 2005 | - | $127.70M(+22.7%) |
| Dec 2004 | $104.10M(+6.8%) | $104.10M(-8.0%) |
| Sep 2004 | - | $113.20M(+2.8%) |
| Jun 2004 | - | $110.10M(-3.0%) |
| Mar 2004 | - | $113.50M(+16.4%) |
| Dec 2003 | $97.50M(+10.4%) | $97.50M(-15.7%) |
| Sep 2003 | - | $115.60M(-7.1%) |
| Jun 2003 | - | $124.40M(-0.4%) |
| Mar 2003 | - | $124.90M(+41.4%) |
| Dec 2002 | $88.30M(+3.5%) | $88.30M(-22.0%) |
| Sep 2002 | - | $113.20M(-1.0%) |
| Jun 2002 | - | $114.40M(+4.7%) |
| Mar 2002 | - | $109.30M(+28.1%) |
| Dec 2001 | $85.30M(-20.3%) | $85.30M(-28.3%) |
| Sep 2001 | - | $119.00M(+2.2%) |
| Jun 2001 | - | $116.40M(-14.5%) |
| Mar 2001 | - | $136.20M(+27.3%) |
| Dec 2000 | $107.00M(-19.5%) | $107.00M |
| Dec 1999 | $133.00M | - |
FAQ
- What is Edwards Lifesciences annual accounts receivable?
- What is the all time high annual accounts receivable for Edwards Lifesciences?
- What is Edwards Lifesciences annual accounts receivable year-on-year change?
- What is Edwards Lifesciences quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Edwards Lifesciences?
- What is Edwards Lifesciences quarterly accounts receivable year-on-year change?
What is Edwards Lifesciences annual accounts receivable?
The current annual accounts receivable of EW is $609.10M
What is the all time high annual accounts receivable for Edwards Lifesciences?
Edwards Lifesciences all-time high annual accounts receivable is $771.50M
What is Edwards Lifesciences annual accounts receivable year-on-year change?
Over the past year, EW annual accounts receivable has changed by -$162.40M (-21.05%)
What is Edwards Lifesciences quarterly accounts receivable?
The current quarterly accounts receivable of EW is $669.20M
What is the all time high quarterly accounts receivable for Edwards Lifesciences?
Edwards Lifesciences all-time high quarterly accounts receivable is $817.60M
What is Edwards Lifesciences quarterly accounts receivable year-on-year change?
Over the past year, EW quarterly accounts receivable has changed by -$148.40M (-18.15%)